The growth in the historic period can be attributed to need for alternative stem cell sources, growth of transplant medicine, limited donor availability, expansion of cord blood banks, advancements in cryopreservation.
The growth in the forecast period can be attributed to growth in stem cell research funding, rising transplant success rates, expansion of regenerative therapies, increased awareness of cord blood benefits, healthcare infrastructure development. Major trends in the forecast period include growing adoption of cord blood stem cell therapy, expansion of hematopoietic transplant procedures, rising use in regenerative medicine, strengthening of cord blood banking, advancements in cell processing technologies.
The rising incidence of blood disorders is expected to drive the growth of the ducord market in the coming years. Blood disorders are conditions that affect the production, function, or structure of blood cells, resulting in issues such as anemia, hemophilia, sickle cell disease, and clotting disorders. The increasing prevalence of these conditions is attributed to genetic predispositions, an aging population, environmental factors, and lifestyle changes. Ducord, a stem cell-based therapy, helps patients with blood disorders by leveraging the regenerative potential of cord blood stem cells to treat conditions like leukemia, anemia, and immune deficiencies, offering an alternative to traditional treatments and the possibility of long-term remission. For example, in April 2024, the Centers for Disease Control and Prevention reported 2.8 million physician office visits for anemia as the primary diagnosis, with 6,021 deaths, resulting in a mortality rate of 1.8 per 100,000 population. Therefore, the growing incidence of blood disorders is driving the ducord market.
The increasing demand for minimally invasive treatments is also expected to support the growth of the ducord market. Minimally invasive treatments are medical procedures that involve small or no incisions, offering faster recovery, lower risks, and shorter hospital stays compared with traditional surgeries. The rising demand is driven by factors such as improved patient outcomes, reduced recovery times, and greater health awareness. Ducord develops innovative devices, including catheters, endoscopes, and diagnostic tools, to support minimally invasive procedures, allowing physicians to perform treatments with smaller incisions and reduced complications. For instance, in April 2025, the British Association of Aesthetic Plastic Surgeons reported that cosmetic surgical procedures in the UK increased by 5% between 2023 and 2024, reaching a total of 27,462 procedures. Therefore, growing demand for minimally invasive treatments is contributing to the growth of the ducord market.
Rising healthcare spending is also expected to drive the growth of the ducord market. Healthcare spending encompasses funds allocated for medical services, treatments, and related healthcare activities. Factors such as an aging population, rising prevalence of chronic diseases, and advancements in medical technology contribute to increased spending. Healthcare expenditure supports Ducord by providing funding for research, development, and clinical trials, enabling the advancement and accessibility of innovative stem cell therapies that can transform the treatment of blood disorders. For example, in May 2024, the Office for National Statistics reported that healthcare spending in the UK increased by 5.6% between 2022 and 2023, compared with 0.9% growth in 2022, reaching approximately $317.63 billion (£292 billion) in 2023. Therefore, rising healthcare spending is supporting the growth of the ducord market.
Major companies operating in the ducord market are Duke University School Of Medicine.
North America was the largest region in the ducord market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ducord market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ducord market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs have influenced the ducord market by increasing costs related to cryopreservation equipment, cell processing materials, and international transport logistics. These cost pressures have affected transplant centers and research institutions, particularly in import dependent regions. North america and europe face moderate exposure, while asia pacific shows rising sensitivity. At the same time, tariffs have encouraged local cord blood banking infrastructure and improved long term therapy accessibility.
The ducord market research report is one of a series of new reports that provides ducord market statistics, including ducord industry global market size, regional shares, competitors with a ducord market share, detailed ducord market segments, market trends and opportunities, and any further data you may need to thrive in the ducord industry. This ducord market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ducord is a stem cell therapy derived from umbilical cord blood, primarily used in hematopoietic stem cell transplants. It supports the regeneration of blood and immune systems in patients with hematopoietic disorders, including those undergoing myeloablative treatments, and shows potential in treating both genetic and acquired conditions.
The main indications for ducord are hematopoietic stem cell transplantation and regenerative medicine. Hematopoietic stem cell transplantation (HSCT) involves transplanting stem cells to restore blood cell production and immune function in patients with certain blood disorders. Ducord is distributed through cord blood banks, hospitals and transplant centers, and research institutions, and is used in applications such as diagnostics and biomanufacturing.
The ducord market consists of sales of cord blood, cord blood-derived progenitor cells, and cryopreserved cord blood. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The growth in the forecast period can be attributed to growth in stem cell research funding, rising transplant success rates, expansion of regenerative therapies, increased awareness of cord blood benefits, healthcare infrastructure development. Major trends in the forecast period include growing adoption of cord blood stem cell therapy, expansion of hematopoietic transplant procedures, rising use in regenerative medicine, strengthening of cord blood banking, advancements in cell processing technologies.
The rising incidence of blood disorders is expected to drive the growth of the ducord market in the coming years. Blood disorders are conditions that affect the production, function, or structure of blood cells, resulting in issues such as anemia, hemophilia, sickle cell disease, and clotting disorders. The increasing prevalence of these conditions is attributed to genetic predispositions, an aging population, environmental factors, and lifestyle changes. Ducord, a stem cell-based therapy, helps patients with blood disorders by leveraging the regenerative potential of cord blood stem cells to treat conditions like leukemia, anemia, and immune deficiencies, offering an alternative to traditional treatments and the possibility of long-term remission. For example, in April 2024, the Centers for Disease Control and Prevention reported 2.8 million physician office visits for anemia as the primary diagnosis, with 6,021 deaths, resulting in a mortality rate of 1.8 per 100,000 population. Therefore, the growing incidence of blood disorders is driving the ducord market.
The increasing demand for minimally invasive treatments is also expected to support the growth of the ducord market. Minimally invasive treatments are medical procedures that involve small or no incisions, offering faster recovery, lower risks, and shorter hospital stays compared with traditional surgeries. The rising demand is driven by factors such as improved patient outcomes, reduced recovery times, and greater health awareness. Ducord develops innovative devices, including catheters, endoscopes, and diagnostic tools, to support minimally invasive procedures, allowing physicians to perform treatments with smaller incisions and reduced complications. For instance, in April 2025, the British Association of Aesthetic Plastic Surgeons reported that cosmetic surgical procedures in the UK increased by 5% between 2023 and 2024, reaching a total of 27,462 procedures. Therefore, growing demand for minimally invasive treatments is contributing to the growth of the ducord market.
Rising healthcare spending is also expected to drive the growth of the ducord market. Healthcare spending encompasses funds allocated for medical services, treatments, and related healthcare activities. Factors such as an aging population, rising prevalence of chronic diseases, and advancements in medical technology contribute to increased spending. Healthcare expenditure supports Ducord by providing funding for research, development, and clinical trials, enabling the advancement and accessibility of innovative stem cell therapies that can transform the treatment of blood disorders. For example, in May 2024, the Office for National Statistics reported that healthcare spending in the UK increased by 5.6% between 2022 and 2023, compared with 0.9% growth in 2022, reaching approximately $317.63 billion (£292 billion) in 2023. Therefore, rising healthcare spending is supporting the growth of the ducord market.
Major companies operating in the ducord market are Duke University School Of Medicine.
North America was the largest region in the ducord market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ducord market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the ducord market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.
Tariffs have influenced the ducord market by increasing costs related to cryopreservation equipment, cell processing materials, and international transport logistics. These cost pressures have affected transplant centers and research institutions, particularly in import dependent regions. North america and europe face moderate exposure, while asia pacific shows rising sensitivity. At the same time, tariffs have encouraged local cord blood banking infrastructure and improved long term therapy accessibility.
The ducord market research report is one of a series of new reports that provides ducord market statistics, including ducord industry global market size, regional shares, competitors with a ducord market share, detailed ducord market segments, market trends and opportunities, and any further data you may need to thrive in the ducord industry. This ducord market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Ducord is a stem cell therapy derived from umbilical cord blood, primarily used in hematopoietic stem cell transplants. It supports the regeneration of blood and immune systems in patients with hematopoietic disorders, including those undergoing myeloablative treatments, and shows potential in treating both genetic and acquired conditions.
The main indications for ducord are hematopoietic stem cell transplantation and regenerative medicine. Hematopoietic stem cell transplantation (HSCT) involves transplanting stem cells to restore blood cell production and immune function in patients with certain blood disorders. Ducord is distributed through cord blood banks, hospitals and transplant centers, and research institutions, and is used in applications such as diagnostics and biomanufacturing.
The ducord market consists of sales of cord blood, cord blood-derived progenitor cells, and cryopreserved cord blood. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Ducord Market Characteristics
3. Ducord Market Supply Chain Analysis
4. Global Ducord Market Trends and Strategies
5. Ducord Market Analysis of End Use Industries
7. Global Ducord Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Ducord Total Addressable Market (TAM) Analysis for the Market
9. Ducord Market Segmentation
10. Ducord Market Regional and Country Analysis
11. Asia-Pacific Ducord Market
12. China Ducord Market
13. India Ducord Market
14. Japan Ducord Market
15. Australia Ducord Market
16. South Korea Ducord Market
17. Western Europe Ducord Market
18. UK Ducord Market
19. Germany Ducord Market
20. France Ducord Market
21. Eastern Europe Ducord Market
22. North America Ducord Market
23. USA Ducord Market
24. Canada Ducord Market
25. South America Ducord Market
26. Middle East Ducord Market
27. Africa Ducord Market
29. Ducord Market Competitive Landscape and Company Profiles
32. Ducord Market High Potential Countries, Segments and Strategies
33. Appendix
Executive Summary
Ducord Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ducord market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ducord? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ducord market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Indication: Hematopoietic Stem Cell Transplantation; Regenerative Medicine2) By Distribution Channel: Cord Blood Banks; Hospitals and Transplant Centers; Research Institutions
3) By Application: Diagnostics; Biomanufacturing
Companies Mentioned: Duke University School Of Medicine
Countries: Australia; India; China; South Korea; Japan; UK; France; Germany; USA; Canada.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Ducord market report include:- Duke University School Of Medicine
